Protein Modeling And In-Silico Drug Designing Approach

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    Protein Modeling And In-Silico Drug Designing Approach - Presentation Transcript

    1. IN –SILICO DRUG TARGET DESIGNING FOR MIGRAINE UNDER GUIDANCE OF Mr. ARVIND SINGH FACULTY BII,NOIDA,INDIA BY- CHINMAYA MAHAPATRA
    2. INTRODUCTION
      • In-silico Drug Design
      • In silico drug designing is defined as the identification of the drug target molecule by employing computational tools
    3. In silico methods
      • Identifying drug targets via bioinformatics tools.
      • To analyze the target structures for possible binding/ active sites.
      • Generating candidate molecules, checking for their drug likeness.
      • Docking these molecules with the target
      • Ranking them according to their binding affinites
      • Further lead optimization to improve binding characteristics
    4. Steps in Drug Designing
    5. MIGRAINE
      • Migraine is a neurological disorder .A migraine headache is a severe pain that is typically on one side of the head but sometimes on both sides.
      • Migraines can occur at any time of the day and can last a few hours or up to one or two days.
      • Migraine attacks can be very intense, forcing the sufferer to abandon normal daily activities.
      • Migraine is commonly experienced between the ages of 15 and 55.
    6. SYMPTOMS OF MIGRAINE
      • Intense pulsating or throbbing headache
      • Moderate to intense pain affecting daily activities
      • Nausea, vomiting or diarrhea
      • Increased sensitivity to smells
      • Increased sensitivity to sounds
      • Increased sensitivity to light (photophobia)
      • Visual disturbances or ‘aura’
    7. TYPES OF MIGRAINE
      • Common Migraine (migraine without aura)
      • Classical Migraine (migraine with aura)
      • Opthalmoplegic migraine
      • Hemiplegic migraine
      • Basilar type migraine
      • Abdominal migraine
      • Acephalgic migraine
    8. PATHOPHYSIOLOGY
      • Depolarization Theory.
      • Vascular theory
      • Serotonin theory
    9.  
    10. DRUGS PREVIOUSLY PRESCRIBED TO CURE MIGRAINE
      • Paracetamol - It is used to cure normal headaches but not effective in acute cases.
      • Aspirin - Help relieve symtoms of nausea and help prevent vomiting. But effective only if taken early.
      • Sumatriptan - Best drug available
      • Naproxen -Taken with caffiene
      • Ibuprofen -Generally taken with aspirin to be effective
      • Ergotamine -Quite effective but has the side-effect that it itself is very nauseated
      • Feverfew -Herbal medicine
    11.  
    12. DESCRIPTION OF PROCESS WITH SOFTWARES USED
      • TAKING A PROTEIN SEQUENCE FROM NCBI FOR PROTEIN S(WHOSE DEFICIENCY CAUSES MIGRAINE).
      • PROTEIN TAKEN IS BAF85683[Unnamed protein]. THEN PERFORMING ITS BLASTP.
      • BLASTP ( B asic L ocal A lignment S earch T ool For Protein)
      • Uses the BLAST algorithm to compare an amino acid query sequence against a protein sequence database .
    13. BLASTP RESULTS
      • Then taking a known protein similar in nature i.e. P98118(for RABBIT). And performing the comparative modelling through using GENO-3D.
      • GENO-3D
      • GENO-3D i.e. Homology Modeling involves taking a known sequence with an unknown structure and mapping it against a known structure of one or several similar (homologous) proteins .
      • GENO-3D RESULTS
    14.  
      • SINCE THE MODEL 2 IS HAVING THE MAXIMUM SEQUENCE IDENTITY OF 87%. ITS RAMACHANDRAN PLOT IS DRAWN TO PREDICT THE RESIDUES AND THE STEREOCHEMISTRY OF THE UNKNOWN PROTEIN.
      • RAMACHANDRAN PLOTS[USING PROCHECK SOFTWARE]
      • A Ramachandran plot is a way to visualize dihedral angles φ against ψ of amino acid residues in protein structure. It shows the possible conformations of φ and ψ angles for a polypeptide.
    15. BETA SHEET ALPHA LEFTHELIX ALPHA HELIX
      • RAMACHANDRAN PLOT OF MODEL-2
      COLOUR KEY GREEN - ALPHA REGION BLUE - ADDITIONAL ALLOWED REGIONS RED- GENEROUSLY ALLOWED REGIONS
      • SINCE FURTHER INFORMATION ABOUT THE UNNAMED PROTEIN IS NOT AVAILABLE .THE SECOND APPROACH IS TAKEN BY CHOOSING A KNOWN PROTEIN INVOLVED IN MIGRAINE IN THE PDB(PROTEIN DATA BANK). The protein is 2YX8( Crystal structure of the extracellular domain of human RAMP1 ).
      • DS VISUALISER
      • The structure of the protein is visualised through the DS VISUALIZER
      • SEQUENCE AS IN DS VISUALISER
    16. DESINING OF INHIBITOR(LIGAND) FOR THE PROTEIN MOLECULE
      • WHAT IS LIGAND?
      • Ligand is either an atom , ion , or molecule that bonds to a central metal, generally involving formal donation of one or more of its electrons .
      • DESINING OF LIGAND MOLECULE IN CHEMSKETCH
      • CHEMSKETCH :-ACD/ChemSketch is an advanced chemical drawing tool for drawing different chemical structures.
      • Five different drugs previously available were drawn along with their derivatives. The drugs are,
      • -Aspirin
      • -Ibuprofen
      • -Naproxen
      • -Paracetamol
      • -sumatriptan
    17. PROPERTIES OF THE DRUGS THAT WERE CACULATED
      • C log p:- partition (P) or distribution coefficient (D) is the ratio of concentrations of a compound in the two phases of a mixture of two immiscible solvents at equilibrium . Here ratio of (C octanol/C water) is taken.
      • MOLECULAR WEIGHT
      • HYDROGEN BOND DONOR AND ACCEPTORS.
      • CHECKING FOR CALCULATING THE LIPINSKI 5’ RULES.
      • LIPINSKI 5’ RULES ARE –
      • Not more than 5 hydrogen bond donors
      • Not more than 10 hydrogen bond acceptors
      • A molecular weight under 500 g/mol
      • A partition coefficient log P less than 5
    18. TABLE CONTAINING LIGAND WITH THEIR PROPERTIES
    19. FOR LIGAND DERIVATIVES
      • D
    20. DOCKING
      • Docking is a method which predicts the preferred orientation of one molecule to a second when bound to each other to form a stable complex . Knowledge of the preferred orientation in turn may be used to predict the strength of association or binding affinity between two molecules
    21. RESULTS OF DOCKING
      • RESULT FOR DOCKING SHOWING SUMATRIPTAN DERIVATIVE GIVING THE MINIMUM BINDING ENERGY VALUE.
    22. DRUGS,THEIR DERIVATIVES AND THEIR BINDING ENERGY VALUE[EVALUE] -174.74 SUMATRIPTAN DERIVATIVES -162.74 SUMATRIPTAN -120.22 PARACETAMOL DERIVATIVES -156.39 PARACETAMOL -161.20 NAPROXEN DERIVATIVES -156.39 NAPROXEN -155.34 IBUPROFEN DERIVATIVES -147.18 IBUPROFEN -128.96 ASPIRIN DERIVATIVES -136.47 ASPIRIN
    23. RESULTS AND DISCUSSIONS
    24. REFERENCES
      • CLINICAL APPROACH TO HEADACHE IN CHILDREN AND PREVENTIVE THERAPY OF MIGRAINE-KK SINHA(JIACM 2005;6(1):64-2).
      • Migrainous Stroke in a Young Patient Associated with Protein S Deficiency - Sachin Kumar, Naresh Gupta, NP Singh, Sandeep Garg, Sameer Gulati(JIACM 2006;7(2):156-8)
      • Recent advances in the diagnosis and management of migraine- Peter J Goadsby(Journal of medical biology 13May 2008).
      • The Tight-Fit Brain - Study Reveals Brain Swelling As Cause of Migraine Headaches (New Research Unveiled at Physiological meeting at UCL-June 2006).
      • Gene influencing migraine- ScienceDaily (Apr. 21, 2008) (American Journal of Human Genetics) .
      • Protein may promote migraines -Andrew Russo-spring conference,2007 at the UI Carver College of Medicine,U.S.A

    + biinoidabiinoida, 2 years ago

    custom

    1395 views, 0 favs, 0 embeds more stats

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 1395
      • 1395 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 26
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories